nicotinell peppermint lozenges nicotine (as nicotine polacrilex) 4 mg lozenge blister pack
orion laboratories pty ltd t/a perrigo australia - nicotine polacrilex, quantity: 26.66 mg (equivalent: nicotine, qty 4 mg) - tablet, uncoated - excipient ingredients: mannitol; sodium carbonate; aspartame; potassium bicarbonate; sodium alginate; xanthan gum; magnesium stearate; flavour - relief of nicotine withdrawal symptoms including cravings associated with smoking cessation. nicotine lozenges may also be used as part of a smoking reduction strategy by smokers who are unable or not ready to stop smoking abruptly as a step towards stopping smoking. if possible, when stopping smoking, should be used in conjunction with behavioural support program.
nicotinell peppermint lozenges nicotine (as nicotine polacrilex) 2 mg lozenge blister pack
orion laboratories pty ltd t/a perrigo australia - nicotine polacrilex, quantity: 13.33 mg (equivalent: nicotine, qty 2 mg) - tablet, uncoated - excipient ingredients: mannitol; potassium bicarbonate; aspartame; sodium alginate; sodium carbonate; magnesium stearate; xanthan gum; flavour - relief of nicotine withdrawal symptoms including cravings associated with smoking cessation. nicotine lozenges may also be used as part of a smoking reduction strategy by smokers who are unable or not ready to stop smoking abruptly as a step towards stopping smoking. if possible, when stopping smoking, should be used in conjunction with behavioural support program.
nicorette microtab nicotine 2mg sublingual tablet blister pack
johnson & johnson pacific pty ltd - nicotine betadex complex, quantity: 17.1 mg (equivalent: nicotine, qty 2 mg) - tablet, uncoated - excipient ingredients: betadex; magnesium stearate; crospovidone; colloidal anhydrous silica - for the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms thus facilitating smoking cessation in smokers motivated to quit.
nicotine transdermal system- nicotine patch, extended release
wal-mart stores inc - nicotine (unii: 6m3c89zy6r) (nicotine - unii:6m3c89zy6r) - nicotine 21 mg in 24 h - stop smoking aid reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking
nicotine transdermal system- nicotine patch, extended release
sam's west inc - nicotine (unii: 6m3c89zy6r) (nicotine - unii:6m3c89zy6r) - nicotine 21 mg in 24 h - stop smoking aid reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking
nicotine transdermal system- nicotine patch, extended release
target corporation - nicotine (unii: 6m3c89zy6r) (nicotine - unii:6m3c89zy6r) - nicotine 21 mg in 24 h - stop smoking aid reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking
nicotine polacrilex, original- nicotine polacrilex gum, chewing
chain drug consortium, llc - nicotine (unii: 6m3c89zy6r) (nicotine - unii:6m3c89zy6r) - nicotine 2 mg - stop smoking aid - reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking - a sodium-restricted diet - heart disease, recent heart attack, or irregular heartbeat. nicotine can increase your heart rate. - high blood pressure not controlled with medication. nicotine can increase blood pressure. - stomach ulcer or diabetes - history of seizures - using a non-nicotine stop smoking drug - taking prescription medicine for depression or asthma. your prescription dose may need to be adjusted. - mouth, teeth, or jaw problems occur - irregular heartbeat or palpitations occur - you get symptoms of nicotine overdose such as nausea, vomiting, dizziness, diarrhea, weakness, and rapid heartbeat - you have symptoms of an allergic reaction (such as difficulty breathing or rash)
nicotine transdermal system- nicotine kit
dr. reddy's laboratories inc. - nicotine (unii: 6m3c89zy6r) (nicotine - unii:6m3c89zy6r) - nicotine 21 mg in 24 h - stop smoking aid reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking
pharmacy care nicotine lozenges 4mg nicotine (as nicotine polacrilex) lozenge blister pack
orion laboratories pty ltd t/a perrigo australia - nicotine polacrilex, quantity: 26.66 mg (equivalent: nicotine, qty 4 mg) - tablet, uncoated - excipient ingredients: aspartame; sodium alginate; xanthan gum; potassium bicarbonate; magnesium stearate; sodium carbonate; mannitol; flavour - relief of nicotine withdrawal symptoms including cravings associated with smoking cessation. nicotine lozenges may also be used as part of a smoking reduction strategy by smokers who are unable or not ready to stop smoking abruptly as a step towards stopping smoking. if possible, when stopping smoking, should be used in conjunction with behavioural support program.
pharmacy care nicotine lozenges 2mg nicotine (as nicotine polacrilex) lozenge blister pack
orion laboratories pty ltd t/a perrigo australia - nicotine polacrilex, quantity: 13.33 mg (equivalent: nicotine, qty 2 mg) - tablet, uncoated - excipient ingredients: aspartame; xanthan gum; mannitol; sodium alginate; sodium carbonate; magnesium stearate; potassium bicarbonate; flavour - relief of nicotine withdrawal symptoms including cravings associated with smoking cessation. nicotine lozenges may also be used as part of a smoking reduction strategy by smokers who are unable or not ready to stop smoking abruptly as a step towards stopping smoking. if possible, when stopping smoking, should be used in conjunction with behavioural support program.